Anna Vaiopoulou1, Maria Gazouli, Aggeliki Papadopoulou, Athanassios K Anagnostopoulos, George Karamanolis, George E Theodoropoulos, Amosy M'Koma, George T Tsangaris. 1. *Department of Basic Medical Sciences, Laboratory of Biology, School of Medicine, University of Athens †Proteomics Research Unit, Biomedical Research Foundation of the Academy of Athens (IIBEAA) ‡Gastroenterology Unit, 2 Department of Surgery, "Aretaieio" University Hospital," Athens §First Propaedeutic Surgical Department, Hippocration University Hospital, University of Athens, Athens, Greece ||Department of Biochemistry and Cancer Biology, Meharry Medical College School of Medicine, Nashville, TN.
Abstract
OBJECTIVES: Crohn disease (CD) and ulcerative colitis (UC), known collectively as inflammatory bowel diseases (IBDs), are chronic immunoinflammatory pathologies of unknown aetiology. Despite the frequent use of biomarkers in medical practice, there is a relative lack of information regarding validated paediatric biomarkers for IBD. Furthermore, biomarkers proved to be efficacious in adults are frequently extrapolated to the paediatric clinical setting without considering that the pathogenesis of many diseases is distinctly different in children. In the present study, proteomics technology was used to monitor differences in protein expression among adult and young patients with CD, identify a panel of candidate protein biomarkers that may be used to improve prognostic-diagnostic accuracy, and advance paediatric medical care. METHODS: Male and female serum samples from 12 adults and 12 children with active CD were subjected to 2-dimensional gel electrophoresis. Following the relative quantitation of protein spots exhibiting a differential expression between the 2 groups by densitometry, the spots were further characterized by matrix-assisted laser desorption tandem time-of-flight mass spectrometer. The results were confirmed by Western blot analysis. RESULTS: Clusterin was found to be significantly overexpressed in adults with CD, whereas ceruloplasmin and apolipoprotein B-100 were found to be significantly overexpressed in children, indicating that the expression of these proteins may be implicated in the onset or progression of CD in these 2 subgroups of patients. CONCLUSIONS: Interestingly, we found a differential expression of several proteins in adults versus paediatric patients with CD. Undoubtedly, future experiments using a larger cohort of patients with CD are needed to evaluate the relevance of our preliminary findings.
OBJECTIVES:Crohn disease (CD) and ulcerative colitis (UC), known collectively as inflammatory bowel diseases (IBDs), are chronic immunoinflammatory pathologies of unknown aetiology. Despite the frequent use of biomarkers in medical practice, there is a relative lack of information regarding validated paediatric biomarkers for IBD. Furthermore, biomarkers proved to be efficacious in adults are frequently extrapolated to the paediatric clinical setting without considering that the pathogenesis of many diseases is distinctly different in children. In the present study, proteomics technology was used to monitor differences in protein expression among adult and young patients with CD, identify a panel of candidate protein biomarkers that may be used to improve prognostic-diagnostic accuracy, and advance paediatric medical care. METHODS: Male and female serum samples from 12 adults and 12 children with active CD were subjected to 2-dimensional gel electrophoresis. Following the relative quantitation of protein spots exhibiting a differential expression between the 2 groups by densitometry, the spots were further characterized by matrix-assisted laser desorption tandem time-of-flight mass spectrometer. The results were confirmed by Western blot analysis. RESULTS:Clusterin was found to be significantly overexpressed in adults with CD, whereas ceruloplasmin and apolipoprotein B-100 were found to be significantly overexpressed in children, indicating that the expression of these proteins may be implicated in the onset or progression of CD in these 2 subgroups of patients. CONCLUSIONS: Interestingly, we found a differential expression of several proteins in adults versus paediatric patients with CD. Undoubtedly, future experiments using a larger cohort of patients with CD are needed to evaluate the relevance of our preliminary findings.
Authors: I E Koutroubakis; N Malliaraki; E Vardas; E Ganotakis; A N Margioris; O N Manousos; E A Kouroumalis Journal: Eur J Gastroenterol Hepatol Date: 2001-12 Impact factor: 2.566
Authors: Maria Gazouli; Athanasios K Anagnostopoulos; Aggeliki Papadopoulou; Anna Vaiopoulou; Konstantinos Papamichael; Gerassimos Mantzaris; George E Theodoropoulos; Nicholas P Anagnou; George Th Tsangaris Journal: J Crohns Colitis Date: 2013-04-03 Impact factor: 9.071
Authors: Aleixo M Muise; Wei Xu; Cong-Hui Guo; Thomas D Walters; Victorien M Wolters; Ramzi Fattouh; Grace Y Lam; Pingzhao Hu; Ryan Murchie; Mary Sherlock; Juan Cristóbal Gana; Richard K Russell; Michael Glogauer; Richard H Duerr; Judy H Cho; Charlie W Lees; Jack Satsangi; David C Wilson; Andrew D Paterson; Anne M Griffiths; Mark S Silverberg; John H Brumell Journal: Gut Date: 2011-09-07 Impact factor: 23.059
Authors: Antonio F Di Narzo; Carrie Brodmerkel; Shannon E Telesco; Carmen Argmann; Lauren A Peters; Katherine Li; Brian Kidd; Joel Dudley; Judy Cho; Eric E Schadt; Andrew Kasarskis; Radu Dobrin; Ke Hao Journal: J Crohns Colitis Date: 2019-03-30 Impact factor: 9.071
Authors: Sara Salvador-Martín; Bartosz Kaczmarczyk; Rebeca Álvarez; Víctor Manuel Navas-López; Carmen Gallego-Fernández; Ana Moreno-Álvarez; Alfonso Solar-Boga; Cesar Sánchez; Mar Tolin; Marta Velasco; Rosana Muñoz-Codoceo; Alejandro Rodriguez-Martinez; Concepción A Vayo; Ferrán Bossacoma; Gemma Pujol-Muncunill; María J Fobelo; Antonio Millán-Jiménez; Lorena Magallares; Eva Martínez-Ojinaga; Inés Loverdos; Francisco J Eizaguirre; José A Blanca-García; Susana Clemente; Ruth García-Romero; Vicente Merino-Bohórquez; Rafael González de Caldas; Enrique Vázquez; Ana Dopazo; María Sanjurjo-Sáez; Luis A López-Fernández Journal: Pharmaceutics Date: 2021-01-08 Impact factor: 6.321
Authors: Sara Salvador-Martín; Irene Raposo-Gutiérrez; Víctor Manuel Navas-López; Carmen Gallego-Fernández; Ana Moreno-Álvarez; Alfonso Solar-Boga; Rosana Muñoz-Codoceo; Lorena Magallares; Eva Martínez-Ojinaga; María J Fobelo; Antonio Millán-Jiménez; Alejandro Rodriguez-Martinez; Concepción A Vayo; Cesar Sánchez; Mar Tolin; Ferrán Bossacoma; Gemma Pujol-Muncunill; Rafael González de Caldas; Inés Loverdos; José A Blanca-García; Oscar Segarra; Francisco J Eizaguirre; Ruth García-Romero; Vicente Merino-Bohórquez; María Sanjurjo-Sáez; Luis A López-Fernández Journal: Int J Mol Sci Date: 2020-05-09 Impact factor: 5.923